GlassScriptPhysician profile
Mark Joseph Scott
NPI 1346290889
$1,249.38
in general payments reported to CMS, 2019-2025
19 companies · $23.27 in 2025
The $23.27 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $220 · 2021: $14.81 · 2022: $420 · 2023: $263 · 2024: $72.50 · 2025: $23.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $374.88 | 2019-2024 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $119.58 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.97 | 2022-2024 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.81 | 2019-2023 | Ofev |
| Genentech USA, INC. | $86.21 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $82.80 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $76.75 | 2022-2023 | Dupixent |
| Grifols USA, LLC | $69.93 | 2019-2023 | Prolastin-C Liquid |
| Pulmonx Corporation | $46.50 | 2019-2022 | |
| Inogen, INC. | $34.35 | 2022 | |
| Electromed, INC. | $32.84 | 2023 | Smartvest |
| Mayne Pharma Commercial LLC | $23.60 | 2020 | |
| Medtronic, INC. | $23.27 | 2025 | Bis |
| Advanced Respiratory, INC | $18.83 | 2019 | |
| Astellas Pharma US INC | $17.51 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $17.27 | 2022 | |
| Mylan Specialty L.P. | $16.90 | 2023 | Yupelri |
| Philips North America LLC | $14.06 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.